Should I buy Nike shares for my Stocks and Shares ISA before 5 April?

Shares of Nike have lagged the market over the last five years. Is it time for me to buy more for my Stocks and Shares ISA?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young black female footballer training on stadium pitch

Image source: Getty Images

One of the more disappointing holdings in my Stocks and Shares ISA in recent years has been Nike (NYSE: NKE). The stock has fallen 20% over the past year and is only up 11% in five years.

That compares very poorly to the S&P 500‘s 84% return over the last half-decade.

The deadline for the current year’s ISA contributions is midnight on 5 April. Is this a chance to buy more shares before then? Or should I sell up and jog on? Let’s discuss.

Incredible brand

The word ‘iconic’ gets bandied about a lot, but to me Nike is clearly such a brand.

I was wearing Nike trainers decades ago. Yet I still couldn’t walk five minutes out and about today without seeing that famous swoosh on a piece of fabric.

Puma, Ellesse, Reebok and others may come in and out of popularity, but Nike has remained at the top.

Moreover, the company still appears to have plenty of opportunity to grow sales in Asia and Latin America, where rising middles classes have more to spend on premium sportswear.

Innovation issues

However, there’s a snag. Critics argue the firm is relying too much on legacy products like basketball shoes and has stopped innovating.

In Nike’s Q3 earnings call on 21 March, CEO John Donahoe admitted as much: “We need to make adjustments…we must drive a continuous flow of new product innovation“.

Meanwhile, it’s losing market share to newer brands like Hoka and On Running, as well as New Balance, which has surged its popularity.

Additionally, the company has been in the headlines recently regarding its redesign of the St George cross on the new England football kit. Even the Prime Minister waded into the row.

Here, it seems there was a little too much product innovation for some people’s liking!

While this storm should quickly blow over, the possibility that Nike has lost its edge is now a worry for me.

Tepid growth outlook

In Q3, which ended 29 February, the company reported $12.43bn in revenue, a 1% rise year on year.

Net profit of $1.17bn translated into earnings per share (EPS) of $0.77 per share. That was down from $0.79 a year earlier, though it would have been $0.98 but for restructuring charges.

Basically, Nike is cost-cutting to preserve profits and margins, but a lack of growth has become a problem. Sales in China are sluggish. Even management admitted that the company “is not performing to our potential”.

Looking ahead, Nike sees a low-single-digits revenue decline in H1 of FY25 (which begins in June). This reflects weak global consumer sentiment. So there’s not much to get excited about.

My move

If the stock was down in the 15-18 price-to-earnings range, I’d consider buying more shares. This remains a world-class company, after all.

However, Nike is trading at 27 times earnings. That’s a growth stock multiple for a firm that has all-but-stopped growing revenue (at least for now). And that worries me.

Granted, there’s an extremely well-covered dividend yield of 1.6%, but that’s nothing to write home about. A quarter of the FTSE 100 is yielding over 5% right now.

On reflection, I’m putting the stock in the penalty box. I’ll wait for Q4 results in June and make a decision then.

Ben McPoland has positions in Nike. The Motley Fool UK has recommended Nike. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Here’s how investors can aim for £11,363 a year in passive income from £20,000 in this overlooked FTSE media gem

I think this media stock is commonly overlooked by investors looking for high passive income, but it shouldn’t be, given…

Read more »